4.8 Article

ArfGAP1 inhibits mTORC1 lysosomal localization and activation

Journal

EMBO JOURNAL
Volume 40, Issue 12, Pages -

Publisher

WILEY
DOI: 10.15252/embj.2020106412

Keywords

amino acids; ArfGAP1; lysosome; mTORC1; vesicle trafficking

Funding

  1. Cancer Prevention Research Institute of Texas (CPRIT) Scholar Recruitment of First Time, Tenure-Track Faculty Member [RR150032]
  2. Cancer Prevention Research Institute of Texas (CPRIT) High-Impact/High-Risk Research Award [RP160713]
  3. Welch Foundation [I-1927-20170325, I-1927-20200401]
  4. 2017 UT Southwestern President's Research Council Distinguished Researcher Award
  5. American Cancer Society Research Scholar Grant [133894-RSG-19-162-01-TBE]
  6. National Institutes of Health [R01GM129097-01, P20 GM113134/GM/NIGMS, R01 GM123048/GM/NIGMS]

Ask authors/readers for more resources

The study identified ADP-ribosylation factor GTPase-activating protein 1 (ArfGAP1) as a critical regulator of mTORC1, which inhibits cell growth through preventing the lysosomal transport and activation of mTORC1, and is also an independent prognostic factor for the overall survival of pancreatic cancer patients.
The mammalian target of rapamycin complex 1 (mTORC1) integrates nutrients, growth factors, stress, and energy status to regulate cell growth and metabolism. Amino acids promote mTORC1 lysosomal localization and subsequent activation. However, the subcellular location or interacting proteins of mTORC1 under amino acid-deficient conditions is not completely understood. Here, we identify ADP-ribosylation factor GTPase-activating protein 1 (ArfGAP1) as a crucial regulator of mTORC1. ArfGAP1 interacts with mTORC1 in the absence of amino acids and inhibits mTORC1 lysosomal localization and activation. Mechanistically, the membrane curvature-sensing amphipathic lipid packing sensor (ALPS) motifs that bind to vesicle membranes are crucial for ArfGAP1 to interact with and regulate mTORC1 activity. Importantly, ArfGAP1 represses cell growth through mTORC1 and is an independent prognostic factor for the overall survival of pancreatic cancer patients. Our study identifies ArfGAP1 as a critical regulator of mTORC1 that functions by preventing the lysosomal transport and activation of mTORC1, with potential for cancer therapeutics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available